+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Primary Cells - Global Strategic Business Report

  • PDF Icon

    Report

  • 184 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805685
The global market for Primary Cells was estimated at US$1.1 Billion in 2023 and is projected to reach US$1.8 Billion by 2030, growing at a CAGR of 7.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Primary Cells: Essential Tools for Biomedical Research and Drug Development

Primary cells are cells taken directly from living tissue and cultured in vitro, retaining many of the physiological characteristics and functions of the original tissue. Unlike immortalized cell lines, which are modified to proliferate indefinitely, primary cells have a limited lifespan and closely mimic the behavior of cells in the body. These cells are essential tools in biomedical research, toxicology studies, and drug development, where they are used to study normal and pathological cell functions, screen potential drug candidates, and model diseases. Primary cells are derived from various tissues, including blood, skin, liver, and brain, and can be cultured to create models of specific organs or systems. Their ability to provide more accurate and relevant data than cell lines makes primary cells invaluable for researchers seeking to understand complex biological processes and develop effective therapies.

How Are Technological Advancements Enhancing Primary Cells and Their Applications?

Technological advancements have significantly improved the isolation, culture, and application of primary cells, making them more accessible and useful for a wide range of research and development activities. Innovations in cell isolation techniques, such as fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS), have enhanced the ability to obtain pure populations of primary cells with specific characteristics, improving the reliability and reproducibility of experimental results. The development of advanced culture media and supplements has extended the lifespan of primary cells in vitro, allowing for longer experiments and more comprehensive studies. Additionally, the integration of 3D cell culture technologies and organ-on-a-chip systems has enabled the creation of more physiologically relevant models using primary cells, providing better insights into tissue function and disease mechanisms. These technological improvements have expanded the applications and benefits of primary cells, making them essential tools in cutting-edge biomedical research and drug discovery.

What Are the Key Applications and Benefits of Primary Cells?

Primary cells are used in a variety of research and development applications, offering numerous benefits that enhance the accuracy and relevance of scientific studies. In drug development, primary cells are used to screen potential drug candidates for efficacy and toxicity, providing more reliable data on how a drug will behave in the human body. In disease modeling, primary cells are used to create in vitro models of diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions, allowing researchers to study disease mechanisms and test potential therapies in a controlled environment. In personalized medicine, primary cells derived from individual patients are used to develop customized treatments and predict patient responses to specific drugs. The primary benefits of using primary cells include their ability to closely mimic in vivo conditions, provide more accurate data than cell lines, and offer insights into complex biological processes. By providing a relevant and reliable model system, primary cells play a critical role in advancing biomedical research and developing new therapies.

What Factors Are Driving the Growth in the Primary Cells Market?

The growth in the primary cells market is driven by several factors. The increasing demand for more physiologically relevant models in biomedical research and drug development is a significant driver, as primary cells offer a more accurate representation of in vivo conditions compared to cell lines. Technological advancements that improve the isolation, culture, and application of primary cells are also propelling market growth. The rising focus on personalized medicine and the need for patient-specific models in drug development are further boosting demand for primary cells. Additionally, the expansion of research activities in fields such as cancer, immunology, and neuroscience is contributing to market growth, as primary cells are essential for studying these complex biological systems. The growing availability of high-quality primary cells from commercial suppliers, coupled with the increasing use of advanced culture systems, is also supporting market expansion. These factors, combined with continuous innovation in cell culture technologies, are driving the sustained growth of the primary cells market.
 

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Human Primary Cells segment, which is expected to reach US$1.4 Billion by 2030 with a CAGR of a 7.4%. The Animal Primary Cells segment is also set to grow at 5.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $298.2 Million in 2023, and China, forecasted to grow at an impressive 6.7% CAGR to reach $272.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Primary Cells Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Primary Cells Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Primary Cells Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Allcells LLC, American Type Culture Collection (ATCC), Axol Bioscience Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 22 Featured):

  • Allcells LLC
  • American Type Culture Collection (ATCC)
  • Axol Bioscience Ltd.
  • Cell Biologics, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Promocell GmbH
  • Thermo Fisher Scientific, Inc.
  • Zenbio, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Primary Cells - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advancements in 3D Cell Culture Technology Propel Growth in Primary Cells Market
  • Increasing Investment in Stem Cell Research Expands Addressable Market Opportunity
  • CRISPR-Cas9 Technology Adoption Strengthens Business Case for Primary Cells
  • Growing Focus on Regenerative Medicine Drives Demand for Animal Primary Cells
  • Advancements in Biopharmaceuticals Accelerate Demand for Human Primary Cells
  • Expansion of Life Science Research Companies Generates Demand for High-Quality Primary Cells
  • Innovations in Cell Preservation Techniques Strengthen Business Case for Primary Cell Usage
  • Emergence of Organoid Technology Drives Adoption of Primary Cells in Cancer Research
  • Rising Prevalence of Chronic Diseases Expands Addressable Market for Primary Cells
  • Increasing Use of Primary Cells in Toxicology Testing Expands Market Opportunities
  • Growing Complexity of Drug Discovery and Development Generates Demand for Primary Cells
  • Technological Integration with High-Throughput Screening Expands Market Opportunity
  • Advancements in Immuno-oncology Research Propel Growth in Primary Cells Market
  • Adoption of Next-Generation Sequencing (NGS) Techniques in Primary Cell Research Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Human Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Human Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Human Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Animal Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Animal Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Animal Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Life Science Research Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Life Science Research Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Life Science Research Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 16: World Primary Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 17: USA Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 18: USA Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: USA 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 20: USA Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
CANADA
  • TABLE 23: Canada Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 24: Canada Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: Canada 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
JAPAN
  • Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 29: Japan Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Japan Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: Japan 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
CHINA
  • Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 35: China Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: China Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: China 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 38: China Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: China 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
EUROPE
  • Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 41: Europe Recent Past, Current & Future Analysis for Primary Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 42: Europe Historic Review for Primary Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: Europe 16-Year Perspective for Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
FRANCE
  • Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 50: France Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: France Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: France 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 53: France Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: France 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
GERMANY
  • Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 56: Germany Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Germany Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: Germany 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
ITALY
  • TABLE 62: Italy Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Italy Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: Italy 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 68: UK Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: UK Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: UK 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 71: UK Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Rest of Europe Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: Rest of Europe 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Rest of Europe Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: Rest of Europe 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Asia-Pacific Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: Asia-Pacific 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Asia-Pacific Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: Asia-Pacific 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
REST OF WORLD
  • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of World Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of World 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
  • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of World Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of World 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Allcells LLC
  • American Type Culture Collection (ATCC)
  • Axol Bioscience Ltd.
  • Cell Biologics, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Promocell GmbH
  • Thermo Fisher Scientific, Inc.
  • Zenbio, Inc.

Table Information